देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE); VITAMIN D3 (CHOLECALCIFEROL)
FROSST A DIVISION OF MERCK CANADA INC
M05BB03
ALENDRONIC ACID AND CHOLECALCIFEROL
70MG; 2800UNIT
TABLET
ALENDRONIC ACID (ALENDRONATE SODIUM TRIHYDRATE) 70MG; VITAMIN D3 (CHOLECALCIFEROL) 2800UNIT
ORAL
4
Prescription
VITAMIN D
Active ingredient group (AIG) number: 0251575001; AHFS:
CANCELLED PRE MARKET
2016-05-05
_ALENDRONATE-CHOLECALCIFEROL _ _(alendronate sodium/cholecalciferol)_ PRODUCT MONOGRAPH ALENDRONATE-CHOLECALCIFEROL 70/2800 alendronate sodium/cholecalciferol tablets 70 MG ALENDRONATE + 70 MCG CHOLECALCIFEROL (2800 IU VITAMIN D 3 ) ALENDRONATE-CHOLECALCIFEROL 70/5600 alendronate sodium/cholecalciferol tablets 70 MG ALENDRONATE + 140 MCG CHOLECALCIFEROL (5600 IU VITAMIN D 3 ) Bone Metabolism Regulator and Vitamin D FROSST, A DIVISION OF MERCK CANADA INC. 16750 route Transcanadienne Kirkland, QC Canada H9H 4M7 DATE OF REVISION: APRIL 25, 2016 www.merck.ca SUBMISSION CONTROL NO: 193513 _ALENDRONATE-CHOLECALCIFEROL _ _(alendronate sodium/cholecalciferol)_ _Page 2 of 44_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION..........................................................3 SUMMARY PRODUCT INFORMATION .......................................................................3 INDICATIONS AND CLINICAL USE .............................................................................3 CONTRAINDICATIONS ..................................................................................................4 WARNINGS AND PRECAUTIONS .................................................................................4 ADVERSE REACTIONS....................................................................................................8 DRUG INTERACTIONS ..................................................................................................13 DOSAGE AND ADMINISTRATION ..............................................................................16 OVERDOSAGE ................................................................................................................16 ACTION AND CLINICAL PHARMACOLOGY ............................................................17 STORAGE AND STABILITY..........................................................................................21 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................22 PART II: SCIENTIFIC INFORMATION ................... पूरा दस्तावेज़ पढ़ें